General Dynamics heads into September with a sharp internal contradiction: a freshly disclosed activist position at 10% of shares outstanding sits alongside the CEO selling nearly $20 million in stock just days later.
The most newsworthy development is the Schedule 13D/A filed by Longview Asset Management on August 28, disclosing a 10.03% stake — the largest single holder on the register. A 13D filing, rather than the passive 13G form, signals activist intent. That is a significant flag on a $100 billion defense franchise. The caveat, as always with 13D/G filings, is that stakes reflect the position as last disclosed around the 5% threshold; holders can reduce below that level without a further filing. What makes the Longview disclosure more striking is its timing: Chairman and CEO Phebe Novakovic sold roughly $19.5 million in open-market shares on August 3, just weeks prior, across four separate transactions — none of them under a pre-arranged 10b5-1 plan. Option exercises and tax-withholding transactions also appeared in late July, but it is the discretionary open-market sales that carry the signal weight. Over the past 90 days, net insider activity amounts to a net disposal of around 94,700 shares, worth approximately $36 million. The contrast between a major external holder accumulating aggressively and the company's own chief executive reducing is the week's central tension.
Options positioning adds a layer of caution to the picture. The put/call ratio has drifted above its recent average, now running at 0.75 against a 20-day mean of 0.68 — about 1.3 standard deviations higher — and is close to its 52-week high of 0.80. That is not an extreme reading, but the directional drift toward hedging has been consistent across the past two weeks, rising from below 0.60 in early August. The stock is down 1.9% on the week and 3.7% on the month to $369.41, so some of that put activity likely reflects portfolio protection after a soft patch in a name that had outperformed the defense complex sharply year-to-date. Short interest, by contrast, is not a meaningful part of the story: bears hold just over 1% of the free float, borrow costs are negligible at 0.32%, and availability is effectively unlimited. Shorts are a non-event here.
The Street, however, remains largely constructive — and that constructiveness was refreshed recently. After Q2 results in late July, Morgan Stanley raised its target to $465, Wells Fargo lifted to $440, and BNP Paribas moved to $430, with TD Cowen, Susquehanna, and Jefferies all moving higher in the same window. Even the holdouts — Citigroup and RBC — raised numbers while keeping neutral ratings. The consensus mean target of $420 implies roughly 14% upside from current levels. The bull case centers on expanding FY26 unspent budget authority, G700 margin improvement, and better Combat systems contract execution. Bears point to backlog-to-revenue conversion delays in Aerospace and Marine as the persistent friction point. The ORTEX short score of 29.7 is low and has barely moved all month, consistent with a stock where shorting conviction is minimal. The dividend factor score of 99 reflects the company's status as one of the most consistent dividend payers in the sector, though the dividend history data available is stale and should not be read as current yield guidance.
The earnings clock is the next hard catalyst. Q3 results are scheduled for October 21. The most recent print — Q2 on July 29 — produced a 2.8% next-day decline and a 2.3% five-day move lower, despite the guidance raise that preceded the analyst target upgrades. That pattern — beat, raise, sell — is worth noting. The Longview 13D position, the CEO's discretionary selling, and the modest drift toward options hedging will each be re-evaluated in the context of whatever Q3 revenue conversion numbers look like in Aerospace and Marine.
See the live data behind this article on ORTEX.
Open GD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
